Skip to content
New Resource: Psychedelics Drug Development Tracker
Psilocybin Alpha Logo Small
  • Home
  • Psychedelic Companies

      Psychedelic Sector Overview

      Psychedelic Sector Overview Mockup Small 3

      Explore the Psychedelic Sector Landscape visually using our new tool.

      Explore Now

      Company Profiles

      ATAI Life Sciences

      Beckley Psytech

      Better Plant Sciences

      CaaMTech

      Champignon Brands

      Compass Pathways

      Cybin Corp

      Eleusis

      Entheon Biomedical

      Field Trip

      Havn Life

      Hollister Biosciences

      MagicMed Industries

      MindMed

      Mydecine Innovations Group

      Numinus

      Revive Therapeutics

      Tryp Therapeutics

  • Watchlist
  • Data

      Psychedelics Patent Trackers

      We track the latest patents and filings related to psilocybin, MDMA and DMT.

      Psilocybin Patents
      Psilocybin Patent Filings
      MDMA Patents
      DMT Patents

      Psychedelics Drug Development Tracker

      From drug discovery to regulatory approval, we map drug development in psychedelics.

      Psychedelics Drug Development Tracker
  • News
      Weekly Psychedelic Bulletin

      News & Interviews

      Psychedelic Bulletin

      Psychedelics Research Review

  • Learn

      How to Buy Psychedelic Stocks

      Looking to invest in psychedelics? This handy guide explains how to buy stocks and shares outside of Canada.

      Read our Guide

      History & Context

      Future Prospects

      Institutional Interest

      How to Buy Psychedelic Stocks

      Psychedelics Glossary

  • Jobs
  • Contact
Search
Close

Numinus

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation

Numinus announces milestones in compassionate access trial for MDMA-assisted therapy in collaboration with MAPS Public Benefit Corporation

  • Post published:February 18, 2021
  • Post category:Press Release
Numinus Wellness Completes Acquisition of Montreal-based Mindspace Wellbeing

Numinus Wellness Completes Acquisition of Montreal-based Mindspace Wellbeing

  • Post published:February 8, 2021
  • Post category:Press Release
Numinus Wellness Closes Q1 2021 with Strong Cash Position and Industry Firsts

Numinus Wellness Closes Q1 2021 with Strong Cash Position and Industry Firsts

  • Post published:January 29, 2021
  • Post category:Press Release
Numinus Announces Listing of Warrants

Numinus Announces Listing of Warrants

  • Post published:January 22, 2021
  • Post category:Press Release
Numinus Announces Grant of Stock Options

Numinus Announces Grant of Stock Options

  • Post published:January 14, 2021
  • Post category:Press Release
Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectrometer

Numinus Wellness Forges Forward into Psychedelic Discovery Research with the Orbitrap Exploris 120 Mass Spectrometer

  • Post published:January 13, 2021
  • Post category:Press Release
Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products

Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products

  • Post published:January 6, 2021
  • Post category:Press Release
Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

  • Post published:December 29, 2020
  • Post category:Press Release
Numinus Completes First Extraction of its Psilocybe Mushrooms

Numinus Completes First Extraction of its Psilocybe Mushrooms

  • Post published:December 17, 2020
  • Post category:Press Release
Pharmadrug Provides Corporate Update and Balance Sheet Status

Pharmadrug Provides Corporate Update and Balance Sheet Status

  • Post published:December 15, 2020
  • Post category:Press Release

End of content

No more pages to load

Older Posts →

Psilocybin Alpha

The definitive resource for investors in the emergent psychedelic medicine sector. Cut through the shroom stock noise with exclusive news, interviews, data and private financing opportunities.

Quick Links

  • Psychedelic Stocks and Companies
  • News & Interviews
  • Psychedelic Sector Jobs
  • Data Bank

Newsletter

Industry insights and interviews delivered to your inbox. No spam, just valuable information.

Psilocybin Alpha Logo Small
  • Psilocybin Alpha © 2021, All Rights Reserved
  • Privacy Policy
  • Terms of Service